208 related articles for article (PubMed ID: 37068659)
1. Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy.
Zhang F; Xu Z; Jolly KJ
Adv Drug Deliv Rev; 2023 Jun; 197():114827. PubMed ID: 37068659
[TBL] [Abstract][Full Text] [Related]
2. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
Song D; Xu Q
Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
[TBL] [Abstract][Full Text] [Related]
3. Engineering cells for precision drug delivery: New advances, clinical translation, and emerging strategies.
Chao CJ; Zhang E; Zhao Z
Adv Drug Deliv Rev; 2023 Jun; 197():114840. PubMed ID: 37088403
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review.
Wei W; Zhang Y; Lin Z; Wu X; Fan W; Chen J
J Drug Target; 2023 Jan; 31(1):1-13. PubMed ID: 35857432
[TBL] [Abstract][Full Text] [Related]
6. Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization.
Timin AS; Litvak MM; Gorin DA; Atochina-Vasserman EN; Atochin DN; Sukhorukov GB
Adv Healthc Mater; 2018 Feb; 7(3):. PubMed ID: 29193876
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
8. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
9. Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine.
Pearce AK; O'Reilly RK
Bioconjug Chem; 2019 Sep; 30(9):2300-2311. PubMed ID: 31441642
[TBL] [Abstract][Full Text] [Related]
10.
Cevaal PM; Ali A; Czuba-Wojnilowicz E; Symons J; Lewin SR; Cortez-Jugo C; Caruso F
ACS Nano; 2021 Mar; 15(3):3736-3753. PubMed ID: 33600163
[TBL] [Abstract][Full Text] [Related]
11. Obstacles and opportunities in a forward vision for cancer nanomedicine.
de Lázaro I; Mooney DJ
Nat Mater; 2021 Nov; 20(11):1469-1479. PubMed ID: 34226688
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cells in biomedical applications.
Sato W; Zajkowski T; Moser F; Adamala KP
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1761. PubMed ID: 34725945
[TBL] [Abstract][Full Text] [Related]
13. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective.
Zhang J; Jiao J; Niu M; Gao X; Zhang G; Yu H; Yang X; Liu L
Int J Nanomedicine; 2021; 16():6497-6530. PubMed ID: 34588777
[TBL] [Abstract][Full Text] [Related]
14. Organic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myeloid Leukemia.
Hussein Kamareddine M; Ghosn Y; Tawk A; Elia C; Alam W; Makdessi J; Farhat S
Technol Cancer Res Treat; 2019; 18():1533033819879902. PubMed ID: 31865865
[TBL] [Abstract][Full Text] [Related]
15. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
16. Targeted nanomedicines for the treatment of bone disease and regeneration.
Ordikhani F; Zandi N; Mazaheri M; Luther GA; Ghovvati M; Akbarzadeh A; Annabi N
Med Res Rev; 2021 May; 41(3):1221-1254. PubMed ID: 33347711
[TBL] [Abstract][Full Text] [Related]
17. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
Monteiro PF; Travanut A; Conte C; Alexander C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems.
Liu H; Zhu X; Wei Y; Song C; Wang Y
Biomed Pharmacother; 2023 Jan; 157():114065. PubMed ID: 36481408
[TBL] [Abstract][Full Text] [Related]
19. Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions.
Trac N; Ashraf A; Giblin J; Prakash S; Mitragotri S; Chung EJ
ACS Nano; 2023 Apr; 17(7):6165-6177. PubMed ID: 36988207
[TBL] [Abstract][Full Text] [Related]
20. Cell-based carrier for targeted hitchhiking delivery.
Liu T; Gao C; Gu D; Tang H
Drug Deliv Transl Res; 2022 Nov; 12(11):2634-2648. PubMed ID: 35499717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
